JPS5386042A - Diabetes treating agent for oral dosage - Google Patents

Diabetes treating agent for oral dosage

Info

Publication number
JPS5386042A
JPS5386042A JP15069177A JP15069177A JPS5386042A JP S5386042 A JPS5386042 A JP S5386042A JP 15069177 A JP15069177 A JP 15069177A JP 15069177 A JP15069177 A JP 15069177A JP S5386042 A JPS5386042 A JP S5386042A
Authority
JP
Japan
Prior art keywords
oral dosage
treating agent
diabetes treating
diabetes
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15069177A
Other languages
English (en)
Japanese (ja)
Inventor
Deiitsue Giyunteru
Bitsukurumairu Mashiasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Original Assignee
Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte filed Critical Thera Patent GmbH and Co KG Gesellschaft fuer Industrielle Schutzrechte
Publication of JPS5386042A publication Critical patent/JPS5386042A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP15069177A 1976-12-17 1977-12-16 Diabetes treating agent for oral dosage Pending JPS5386042A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762657382 DE2657382A1 (de) 1976-12-17 1976-12-17 Orales antidiabetikmittel

Publications (1)

Publication Number Publication Date
JPS5386042A true JPS5386042A (en) 1978-07-29

Family

ID=5995851

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15069177A Pending JPS5386042A (en) 1976-12-17 1977-12-16 Diabetes treating agent for oral dosage

Country Status (5)

Country Link
US (1) US4146613A (enExample)
JP (1) JPS5386042A (enExample)
DE (1) DE2657382A1 (enExample)
FR (1) FR2374044A1 (enExample)
GB (1) GB1545039A (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009544630A (ja) * 2006-07-26 2009-12-17 デイアメデイカ・インコーポレイテツド 代謝障害の診断及び治療方法
US9839678B2 (en) 2012-06-04 2017-12-12 Diamedica Inc. Human tissue kallikrein 1 glycosylation isoforms
US11857608B2 (en) 2017-03-09 2024-01-02 Diamedica Inc. Dosage forms of tissue kallikrein 1

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2657381C2 (de) * 1976-12-17 1982-03-25 Thera Gesellschaft für Patentverwertung mbH, 8036 Herrsching Glucosehaltige Infusionslösung
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
US20130315891A1 (en) 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357507C3 (de) * 1973-11-17 1980-07-31 Bayer Ag, 5090 Leverkusen Mittel zur Fertilitätssteigemng
DE2658059A1 (de) * 1976-12-22 1978-07-06 Bayer Ag Mittel zur behandlung von krankhaften stoerungen des glukosestoffwechsels

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009544630A (ja) * 2006-07-26 2009-12-17 デイアメデイカ・インコーポレイテツド 代謝障害の診断及び治療方法
JP2013129672A (ja) * 2006-07-26 2013-07-04 Diamedica Inc 代謝障害の診断及び治療方法
US9839678B2 (en) 2012-06-04 2017-12-12 Diamedica Inc. Human tissue kallikrein 1 glycosylation isoforms
US11857608B2 (en) 2017-03-09 2024-01-02 Diamedica Inc. Dosage forms of tissue kallikrein 1
US12329805B2 (en) 2017-03-09 2025-06-17 Diamedica Inc. Dosage forms of tissue kallikrein 1

Also Published As

Publication number Publication date
US4146613A (en) 1979-03-27
FR2374044B1 (enExample) 1982-06-11
FR2374044A1 (fr) 1978-07-13
DE2657382A1 (de) 1978-06-29
GB1545039A (en) 1979-05-02

Similar Documents

Publication Publication Date Title
CY1129A (en) Pharmaceutical dosage forms
JPS5317572A (en) Improvement for treating substances
PH23643A (en) Nasal pharmaceutical composition
JPS52102432A (en) Pharmaceutical composition containing pyretrinoid
JPS52134026A (en) Medical composition
JPS5394029A (en) Medicac composition for oral dose
JPS52125634A (en) Composition for burn treatment
IL52154A (en) Apparatus for tomography
AU3152677A (en) Pharmaceutical composition
JPS52135598A (en) Hand piece for dental treatment
IL51429A (en) Coccidiocidal composition for treating
JPS5369822A (en) Pharmaceutical agent
JPS5386042A (en) Diabetes treating agent for oral dosage
SG41482G (en) Medicaments for treating hypertension
JPS5334930A (en) Medical composition
JPS52120131A (en) Treating composition for rercholesterol disease
JPS5315428A (en) Medical composition
JPS5296750A (en) Oral drug compound
JPS52130925A (en) Mouthhthrough administrating agent for cattle
JPS52113954A (en) Local pharmaceutical agent containing clindamycine
JPS52114010A (en) Medicine for nicotinism
ZA777335B (en) Pharmaceutical compounds
JPS5356698A (en) Composition for treating coccidium disease containing 55deazariboflavin and derivative thereof
JPS5312427A (en) Treating agent for galllstone disease
JPS53127810A (en) Diabetes treating agent